News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,130 Results
Type
Article (87979)
Company Profile (825)
Press Release (781308)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233268)
Career Advice (4147)
Deals (39883)
Drug Delivery (151)
Drug Development (91420)
Employer Resources (205)
FDA (18391)
Job Trends (17428)
News (397929)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (147)
Alliances (56981)
ALS (181)
Alzheimer's disease (1789)
Antibody-drug conjugate (ADC) (346)
Approvals (18573)
Artificial intelligence (626)
Autoimmune disease (161)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (661)
Cancer (5027)
Cardiovascular disease (443)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (825)
Cervical cancer (37)
Clinical research (77012)
Collaboration (1811)
Company closure (5)
Compensation (1151)
Complete response letters (70)
COVID-19 (2992)
CRISPR (99)
C-suite (859)
Cystic fibrosis (154)
Data (6254)
Decentralized trials (2)
Denatured (72)
Depression (150)
Diabetes (532)
Diagnostics (7226)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (302)
Drug pricing (223)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100137)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135067)
Executive appointments (1033)
FDA (21566)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1554)
Gene editing (215)
Generative AI (64)
Gene therapy (670)
GLP-1 (1125)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20945)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (290)
Immuno-oncology (59)
Indications (95)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (247)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (68)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (378)
Machine learning (45)
Management (66)
Manufacturing (850)
MASH (172)
Medical device (15027)
Medtech (15079)
Mergers & acquisitions (22984)
Metabolic disorders (1394)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (354)
Neuropsychiatric disorders (97)
Neuroscience (3105)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (674)
Opinion (335)
Ovarian cancer (166)
Pain (208)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (508)
Patient recruitment (478)
Peanut (60)
People (66906)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23798)
Phase II (33417)
Phase III (25184)
Pipeline (5008)
Policy (335)
Postmarket research (3554)
Preclinical (10692)
Press Release (72)
Prostate cancer (244)
Psychedelics (54)
Radiopharmaceuticals (301)
Rare diseases (896)
Real estate (7439)
Recruiting (80)
Regulatory (29005)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (100)
The Weekly (122)
Vaccines (1146)
Venture capital (96)
Weight loss (462)
Women's health (87)
Worklife (21)
Date
Today (58)
Last 7 days (489)
Last 30 days (2441)
Last 365 days (32875)
2026 (2441)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51556)
Australia (9052)
California (11517)
Canada (3308)
China (1164)
Colorado (488)
Connecticut (499)
Delaware (345)
Europe (118437)
Florida (1686)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (963)
India (67)
Indiana (542)
Iowa (24)
Japan (427)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1455)
Massachusetts (8481)
Michigan (358)
Minnesota (664)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3100)
New Mexico (33)
New York (3041)
North Carolina (1609)
North Dakota (10)
Northern California (5505)
Ohio (354)
Oklahoma (22)
Oregon (54)
Pennsylvania (2306)
Puerto Rico (22)
Rhode Island (50)
South America (1661)
South Carolina (65)
South Dakota (1)
Southern California (4445)
Tennessee (176)
Texas (1817)
United States (41568)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (970)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
There are 870,130 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
FDA’s Multiple Myeloma Guidance Highlights Decade of Success
New draft guidance from the FDA on multiple myeloma endpoints reflects the new technology available to assess disease and how patient journeys have changed with better treatments.
January 30, 2026
·
4 min read
·
Dan Samorodnitsky
Drug pricing
TrumpRx Delayed Amid Potential Anti-Kickback Concerns
In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live “probably in the next 10 days,” but an exact launch date remains unclear.
January 30, 2026
·
2 min read
·
Tristan Manalac
Deals
Moderna Teams With Recordati on Rare Disease mRNA Therapy for up to $160M
Moderna will continue to lead clinical development and manufacturing of the asset, while Recordati will handle commercialization of mRNA-3927, which is under development for the rare metabolic disorder propionic acidemia.
January 30, 2026
·
1 min read
·
Annalee Armstrong
Obesity
AstraZeneca’s China Trip Yields CSPC Obesity Deal Worth $1.2B Upfront
The pact, which could see AstraZeneca ultimately put out $18.5 billion in milestones and sales-based payments, is centered on SYH2082, a long-acting dual agonist of the GLP-1 and GIP receptors.
January 30, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence
Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
January 30, 2026
·
2 min read
·
Tristan Manalac
Regulatory
Summit’s Potential Keytruda Rival Gets November FDA Decision Date
The FDA is currently reviewing Summit’s PD-1/VEGF bispecific as part of a chemotherapy combo for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer.
January 30, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Merz Therapeutics Appoints Dan Staner as President, Region Europe
January 30, 2026
·
2 min read
Press Releases
Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
January 30, 2026
·
6 min read
Press Releases
Idorsia to present long-term lucerastat data and kidney biopsy results at WORLDSymposium
January 30, 2026
·
9 min read
Press Releases
Vaxcyte Announces Pricing of $550 Million Public Offering
January 30, 2026
·
4 min read
1 of 87,013
Next
